Skip to main content
Clinical Epigenetics logoLink to Clinical Epigenetics
. 2021 Mar 30;13:67. doi: 10.1186/s13148-021-01059-9

Correction to: Transient receptor potential ankyrin 1 promoter methylation and peripheral pain sensitivity in Crohn’s disease

Sara Gombert 1,, Mathias Rhein 1, Andreas Winterpacht 2, Tino Münster 3,4, Thomas Hillemacher 1,5, Andreas Leffler 6, Helge Frieling 1
PMCID: PMC8011209  PMID: 33785061

Correction to: Clinical Epigenetics (2020) 12:1 https://doi.org/10.1186/s13148-019-0796-9

Following publication of the original article [1], an error was identified in the use of reference 42 which was cited insufficiently. Data of healthy participants, which were used for comparison with the Crohn patient group in Figures 1, 2, 4 and 5, and Table 2, were already analyzed and published previously in:

  • 42.

    Gombert S, Rhein M, Eberhardt M, Munster T, Bleich S, Leffler A, et al. Epigenetic divergence in the TRPA1 promoter correlates with pressure pain thresholds in healthy individuals. Pain. 2017;158(4):698–704. Epub 2016/12/29.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Gombert S, Rhein M, Winterpacht A, Münster T, Hillemacher T, Leffler A, Frieling H. Transient receptor potential ankyrin 1 promoter methylation and peripheral pain sensitivity in Crohn’s disease. Clin Epigenet. 2020;12:1. doi: 10.1186/S13148-019-0796-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Epigenetics are provided here courtesy of BMC

RESOURCES